臨床試驗

REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness

NCT：NCT07792252 · NOT_YET_RECRUITING

NCT IDNCT07792252

狀態NOT_YET_RECRUITING

SponsorYale University (OTHER)

First posted2026-08-28

Last updated2026-09-09

簡要摘要

Rejoyn is a Prescription Digital Therapeutic (PDT) for adults with Major Depressive Disorder (MDD). This study aims to evaluate the feasibility, engagement, and clinical context of integrating Rejoyn into standard interventional workflows at the Yale New Haven Hospital Interventional Psychiatry Service (IPS). This is a non-significant risk, observational real-world evidence (RWE) study.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。